News about Global Pharma

Sense Diagnostics Appoints Gary Kurdziel as Chief Executive Officer, Effective from April 1, 2025

Sense Diagnostics, Inc. announced that its board of directors has appointed Gary Kurdziel as Chief Executive Officer, effective April 1, 2025. Kurdziel, who most recently served as EVP and CCO for Sense Neuro Diagnostics, brings extensive global leadership experience spanning more than three decades in the medical device industry.

Global Pharma | 25/03/2025 | By Manvi |  276

Oxford BioTherapeutics and Roche to Research on Novel Targets for Antibody-Based Therapeutics

OBT’s recently launched enhanced proprietary OGAP®-Verify discovery platform enables greater sensitivity and thereby the selection of targets with improved attributes for drug development.

Global Pharma | 25/03/2025 | By Aishwarya |  259

Syngene International to Procure Renewable Energy from O2 Power

Syngene International Ltd., a Biocon subsidiary, will procure renewable energy from O2 Power’s 201.2 MW wind-solar hybrid plant in Karnataka under a captive arrangement. The company acquired 33.79 percent stake in the SPV for INR 6.5 crore.

Global Pharma | 25/03/2025 | By Manvi |  411

Wheeler Bio Plans for Expansion with Closing of Oversubscribed Series A-1 Financing Round

The USD 35 million round was led by Alloy Therapeutics and Echo Investment Capital (Echo), with participation from Mitsubishi Corporation (Americas), Germin8 Ventures, and Russell Westbrook Enterprises.

Global Pharma | 25/03/2025 | By Aishwarya |  297

Chang Gung Memorial Hospital Leads Taiwan with 12,000+ Robotic Surgeries

By the end of 2024, the hospital had performed over 12,000 robotic surgeries, accounting for one-sixth of Taiwan's robotic procedures and cementing its leadership in the field. With its technical expertise and clinical achievements, Chang Gung is steering Taiwan into a new era of minimally invasive surgery worldwide with its robust healthcare system.

Global Pharma | 24/03/2025 | By Manvi |  219

SMS Pharma Announces Successful Completion of USFDA Inspection at Hyderabad API Facility

SMS Pharmaceuticals has successfully completed a USFDA inspection at its Bachupally API facility in Hyderabad, receiving one procedural observation with no impact on data integrity or product quality.

Global Pharma | 24/03/2025 | By Manvi |  625

Sanofi to Acquire Dren Bio Bispecific Myeloid Cell Engager for Deep B-Cell Depletion

DR-0201 is a potential first-in-class CD20-directed bispecific antibody that targets and engages specific tissue-resident and trafficking myeloid cells to induce deep B-cell depletion via targeted phagocytosis.

Global Pharma | 24/03/2025 | By Aishwarya |  204

BrePco and Piramal Receive UK MHRA Approval for Neoatricon Paediatric Dopamine Formula

Neoatricon, developed by BrePco Biopharma, is an age-appropriate, ready-to-use, sterile solution available in two concentrations: 1.5 mg/mL in a 30 mL vial and a higher strength of 4.5 mg/mL in a 50 mL vial.

Global Pharma | 24/03/2025 | By Aishwarya |  345

Syneron Bio Signs Strategic Partnership with AstraZeneca

Under this collaboration, AstraZeneca will gain access to Syneron Bio's innovative Synova™ platform, an intelligent and high-throughput macrocyclic peptide drug research and development platform, designed to support the advancements of research programmes exploring possible future treatments of chronic diseases.

Global Pharma | 24/03/2025 | By Aishwarya |  994

Hansoh Pharma Expands Indications for Merigolix with Initiation of ART Development

Hansoh Pharma recently received approval for an IND (Investigational New Drug) application targeting ART, expanding the development area of merigolix.

Global Pharma | 21/03/2025 | By Aishwarya |  422